| Project Detail |
Reducing malaria morbidity and mortality in the population especially children children under 5 years and pregnant women and also the grant ensures provision of equitable access to essential medicines, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness.
Objectives
By end of 2025, reduce malaria burden by 75% (11% overall prevalence) compared to 2016 (45% prevalence). The project comprises four objectives which include: 1. By end of 2025, reduce malaria case incidence by at least 75% (43/100,000 population) compared to 2016 (172/100,000 population. 2. By end of 2025, reduce malaria case incidence by at least 75% (95/1,000 population) compared to 2016 (380/1,000 population. 3. By end of 2025, promote and maintain a culture of evidence-based decision-making to achieve malaria program performance at all levels. 4. By end of 2025, strengthen and maintain capacity for program management, coordination, and partnership to achieve malaria program performance at all levels. |
